Satellite Symposia Program
WEDNESDAY, DECEMBER 3, 2008
14:45–16:15 MSD: Osteoporosis – Present and Future
14:45–16:15 WYETH: New Frontiers in Assessment of Fracture Risk
16:45–18:15 AMGEN: RANK Ligand Inhibition: A Future Strategy for the Management of Postmenopausal Osteoporosis?
THURSDAY, DECEMBER 4, 2008
17:15–18:45 ELI LILLY: New Tactics for Skeletal Health Preservation
17:15–18:45 SERVIER: Fighting Osteoporosis: The Rational Answer
FRIDAY, DECEMBER 5, 2008
17:15–18:45 SANOFI AVENTIS and PROCTER & GAMBLE PHARMACEUTICALS (ABBH): Emerging Clinical Evidence in the Differences Among Bisphosphonates
17:15–18:45 MEDTRONIC: New Clinical Evidence in the Treatment of Vertebral Compression Fractures: Balloon Kyphoplasty vs. Non-surgical Management
SATURDAY, DECEMBER 6, 2008
17:15–18:45 ROCHE: Improving Bone Strength and Reducing Fractures: A Review of Current Evidence
WEDNESDAY, DECEMBER 3, 2008
14:45–16:15
PLENARY HALL 3
Osteoporosis – Present and Future
Satellite Symposium presented by MSD
Welcome and opening remarks
S. BAVONRATANAVECH
Osteoporosis in Asia: Strategies in addressing under-treatment and vitamin D inadequacy
S.P. CHAN
Treatment of postmenopausal osteoporosis: Who and how long to treat
J.A. KANIS
Odanacatib clinical update: A new mechanism to target bone remodelling
J. EISMAN
Question and Answer
14:45–16:15
PLENARY HALL 2
New Frontiers in Assessment of Fracture Risk
Satellite Symposium presented by WYETH
Chairman: A.W. KUNG
Introduction
A.W. KUNG
Vertebral and non-vertebral fractures – Epidemiology
D.M. BLACK
Fracture risk, FRAX™ and response to treatment
E.V. MCCLOSKEY
Questions / Conclusion
A.W. KUNG
16:45–18:15
PLENARY HALL 3
RANK Ligand Inhibition: A Future Strategy for the Management of Postmenopausal Osteoporosis?
Satellite Symposium presented by AMGEN
Chairman: E. SEEMAN
RANK ligand inhibition as a new concept in targeting the osteoclast
R.G. RUSSELL
The therapeutic potential of RANK ligand inhibition in patients with low bone mass
E.V. MCCLOSKEY
The effect of RANK ligand inhibition on fracture occurrence in patients with postmenopausal osteoporosis
S.R. CUMMINGS
THURSDAY, DECEMBER 4, 2008
17:15–18:45
PLENARY HALL 2
New Tactics for Skeletal Health Preservation
Satellite Symposium presented by ELI LILLY
Chairman: J.A. KANIS
Welcome and overview
J.A. KANIS
Effects of anti-resorptives on bone quality in postmenopausal women with osteoporosis
S. MORI
SERMs for prevention of fracture and invasive breast cancer: Who should be treated?
S.R. CUMMINGS
Safety profile of SERMs: Focus on the uterus
P. HADJI
Effects of teriparatide treatment in patients with glucocorticoid-induced osteoporosis
C. COOPER
Conclusion / Question and Answer
J.A. KANIS
17:15–18:45
PLENARY HALL 3
Fighting Osteoporosis: The Rational Answer
Satellite Symposium presented by SERVIER
Co-Chairs: S. BAVONRATANAVECH and E. SEEMAN
Introduction
S. BAVONRATANAVECH
Bone modelling and remodelling: The heart beat of a living tissue
E. SEEMAN
A physiological approach for better bone quality
N.A.T. HAMDY
Strontium ranelate: Clinical benefits confirmed in Asian population
A.W. KUNG
Treating bone as a living tissue: A step forward in fracture prevention
J.Y. REGINSTER
Conclusion
E. SEEMAN
FRIDAY, DECEMBER 5, 2008
17:15–18:45
PLENARY HALL 3
Emerging Clinical Evidence in the Differences Among Bisphosphonates
Satellite Symposium presented by Sanofi Aventis and Procter & Gamble Pharmaceuticals (ABBH)
Co-chairs: E. SEEMAN and P. YUKTANANDANA
Interpreting clinical trial data: How important are the differences between bisphosphonates?
J.P. BILEZIKIAN
Consequences of differences in structure-function relationships among bisphosphonates
R.G. RUSSELL
Beyond randomised controlled trials: REAL-life effectiveness in osteoporosis management
S. FERRARI
17:15–18:45
PLENARY HALL 2
New Clinical Evidence in the Treatment of Vertebral Compression Fractures: Balloon Kyphoplasty vs. Non-surgical Management
Satellite Symposium presented by MEDTRONIC
Chairman: S. BOONEN
Introduction / Overview
S. BOONEN
Is conservative management conservative? The impact of vertebral body compression fractures treated non-operatively on health and quality of life
S. BOONEN
Balloon kyphoplasty – A minimally invasive procedure for vertebral compression fractures
J. VAN MEIRHAEGHE
Fracture REduction Evaluation (FREE) – A randomized trial of balloon kyphoplasty and nonsurgical care for patients with acute vertebral compression fractures: 1 year results
S.R. CUMMINGS
Balloon kyphoplasty for patients with painful vertebral compression fractures: Japanese study
D. TOGAWA
Future studies / Closing / Q&A
S. BOONEN
SATURDAY, DECEMBER 6, 2008
17:15–18:45
PLENARY HALL 2
Improving Bone Strength and Reducing Fractures: A Review of Current Evidence
Satellite Symposium presented by ROCHE
Co-chairs: K.S. TSAI and C. COOPER
Welcome and introduction
K.S. TSAI
The significance of surrogate markers in fracture outcomes
S. EPSTEIN
Current and future imaging techniques: Clinical implications for assessing bone strength
M.L. BOUXSEIN
Ibandronate: A focus on anti-fracture efficacy
C. COOPER
Summary
C. COOPER
|
